The government’s Cancer Drugs Fund ‘makes no sense’ the head of the NHS drugs rationing body has said.

Sir Andrew Dillon, the chief executive of NICE said that it was irrational that the fund approved drugs which NICE had already turned down.

NICE has come under intense criticism for refusing to fund life-extending drugs for cancer.

Last month the body turned down Kadcyla – which adds six months of life on average to women dying with an aggressive form of breast cancer.

Patients have been increasingly forced to resort to the Cancer Drugs Fund.

But yesterday Sir Andrew said the fund should be brought under the remit of NICE, because funding for drugs had become ‘misaligned.’

“We would like to move away from a situation where we apply our correct threshold we say yes to we say we can’t support routine use of other treatments, and in most cases the Cancer Drugs Fund then says yes to the treatments we have said no to,” he told MPs on the Health Select Committee.

“I don’t think that makes any sense. It’s not a criticism of the decision to allocate more money to cancer. It’s about an alignment of processes and methodologies that we need to get sorted out.

For more details, go to: http://www.telegraph.co.uk/health/healthnews/11071055/Cancer-Drugs-Fund-makes-no-sense-says-head-of-drugs-rationing-body-Nice.html